Eluminex Biosciences
Suzhou
About Eluminex Biosciences
Eluminex Biosciences is dedicated to the research and commercialization of novel therapies to address unmet medical needs in the diagnosis, treatment, and control of ocular illnesses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $100.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2023)
- Website: eluminexbio.com
- Phone: [email protected]
Industries & Categories
Health Diagnostics, Therapeutics
Canonical: https://fsome.com/organization/eluminex-biosciences-24029 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.